New therapy update. Inspra (eplerenone tablets).
Kloner
Robert A
RA
D004232:Diuretics / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use*; D000077545:Eplerenone; D006333:Heart Failure / Q000188:drug therapy / Q000453:epidemiology; D006801:Humans; D006947:Hyperkalemia / Q000139:chemically induced / Q000453:epidemiology; D006973:Hypertension / Q000188:drug therapy / Q000453:epidemiology; D000451:Mineralocorticoid Receptor Antagonists / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use*; D009203:Myocardial Infarction / Q000188:drug therapy / Q000453:epidemiology; D012307:Risk Factors; D013148:Spironolactone / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000494:pharmacology* / Q000627:therapeutic use*; D013318:Stroke Volume / Q000187:drug effects; D018487:Ventricular Dysfunction, Left / Q000188:drug therapy / Q000453:epidemiology
D004232:Diuretics; D000451:Mineralocorticoid Receptor Antagonists; D013148:Spironolactone; D000077545:Eplerenone